DE2705582C3 - 5-(Pyridazin-3-yl)-1,2-dithiol-3-thion, seine Herstellung und die es enthaltenden Zusammensetzungen - Google Patents

5-(Pyridazin-3-yl)-1,2-dithiol-3-thion, seine Herstellung und die es enthaltenden Zusammensetzungen

Info

Publication number
DE2705582C3
DE2705582C3 DE2705582A DE2705582A DE2705582C3 DE 2705582 C3 DE2705582 C3 DE 2705582C3 DE 2705582 A DE2705582 A DE 2705582A DE 2705582 A DE2705582 A DE 2705582A DE 2705582 C3 DE2705582 C3 DE 2705582C3
Authority
DE
Germany
Prior art keywords
pyridazin
compound
general formula
compositions
thione
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2705582A
Other languages
German (de)
English (en)
Other versions
DE2705582B2 (US06312121-20011106-C00033.png
DE2705582A1 (de
Inventor
Claude Paris Cotrel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Industries SA
Original Assignee
Rhone Poulenc Industries SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7603603A external-priority patent/FR2340736A1/fr
Priority claimed from FR7636038A external-priority patent/FR2371925A1/fr
Application filed by Rhone Poulenc Industries SA filed Critical Rhone Poulenc Industries SA
Publication of DE2705582A1 publication Critical patent/DE2705582A1/de
Publication of DE2705582B2 publication Critical patent/DE2705582B2/de
Application granted granted Critical
Publication of DE2705582C3 publication Critical patent/DE2705582C3/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
DE2705582A 1976-02-10 1977-02-10 5-(Pyridazin-3-yl)-1,2-dithiol-3-thion, seine Herstellung und die es enthaltenden Zusammensetzungen Expired DE2705582C3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7603603A FR2340736A1 (fr) 1976-02-10 1976-02-10 Nouveaux derives du dithiole-1,2, leur preparation et les compositions qui les contiennent
FR7636038A FR2371925A1 (fr) 1976-11-30 1976-11-30 Nouveaux derives du dithiole-1,2, leur preparation et les compositions qui les contiennent

Publications (3)

Publication Number Publication Date
DE2705582A1 DE2705582A1 (de) 1977-08-11
DE2705582B2 DE2705582B2 (US06312121-20011106-C00033.png) 1980-08-21
DE2705582C3 true DE2705582C3 (de) 1981-09-24

Family

ID=26219292

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2705582A Expired DE2705582C3 (de) 1976-02-10 1977-02-10 5-(Pyridazin-3-yl)-1,2-dithiol-3-thion, seine Herstellung und die es enthaltenden Zusammensetzungen

Country Status (22)

Country Link
US (1) US4104386A (US06312121-20011106-C00033.png)
JP (1) JPS52105181A (US06312121-20011106-C00033.png)
AR (1) AR220892A1 (US06312121-20011106-C00033.png)
AT (2) AT349028B (US06312121-20011106-C00033.png)
AU (1) AU505778B2 (US06312121-20011106-C00033.png)
CA (1) CA1075239A (US06312121-20011106-C00033.png)
CH (1) CH616161A5 (US06312121-20011106-C00033.png)
DE (1) DE2705582C3 (US06312121-20011106-C00033.png)
DK (1) DK55677A (US06312121-20011106-C00033.png)
EG (1) EG13192A (US06312121-20011106-C00033.png)
ES (1) ES458019A1 (US06312121-20011106-C00033.png)
GB (1) GB1520231A (US06312121-20011106-C00033.png)
HU (1) HU172527B (US06312121-20011106-C00033.png)
IE (1) IE44462B1 (US06312121-20011106-C00033.png)
IL (1) IL51402A (US06312121-20011106-C00033.png)
LU (1) LU76727A1 (US06312121-20011106-C00033.png)
NL (1) NL175823C (US06312121-20011106-C00033.png)
OA (1) OA05566A (US06312121-20011106-C00033.png)
PH (1) PH12622A (US06312121-20011106-C00033.png)
PT (1) PT66174B (US06312121-20011106-C00033.png)
SE (1) SE427273B (US06312121-20011106-C00033.png)
SU (1) SU837324A3 (US06312121-20011106-C00033.png)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1454910A1 (en) 2003-03-07 2004-09-08 Sanofi-Synthelabo Substituted pyrimidinyl-2-(diaza-bicyclo-alkyl)-pyrimidone derivatives
TW200740779A (en) * 2005-07-22 2007-11-01 Mitsubishi Pharma Corp Intermediate compound for synthesizing pharmaceutical agent and production method thereof
EP1939187A1 (en) 2006-12-20 2008-07-02 Sanofi-Aventis Substituted heteroaryl pyridopyrimidone derivatives
EP2085400A1 (en) * 2008-01-29 2009-08-05 Sanofi-Aventis Substituted heteroarylamide oxazepinopyrimidone derivatives
EP2090578A1 (en) * 2008-01-29 2009-08-19 Sanofi-Aventis Substituted arylamide diazepinopyrimidone derivatives for the treatment of neurodegenerative diseases caused by abnormal activity of GSK3-beta
EP2090579A1 (en) * 2008-01-29 2009-08-19 Sanofi-Aventis Substituted heteroarylamide diazepinopyrimidone derivatives
EP2085399A1 (en) 2008-01-29 2009-08-05 Sanofi-Aventis substituted arylamide oxazepinopyrimidone derivatives
EP2138493A1 (en) * 2008-06-26 2009-12-30 Sanofi-Aventis Substituted pyrimidone derivatives
EP2138492A1 (en) * 2008-06-26 2009-12-30 Sanofi-Aventis Substituted pyrimidin-4-one derivatives
EP2138494A1 (en) * 2008-06-26 2009-12-30 Sanofi-Aventis Substituted alkyl pyrimidin-4-one derivatives
EP2138498A1 (en) * 2008-06-26 2009-12-30 sanofi-aventis Substituted tricyclic derivatives against neurodegenerative diseases
EP2138495A1 (en) * 2008-06-26 2009-12-30 sanofi-aventis Substituted pyrimido[2,1-a]isoquinolin-4-one derivatives
EP2138485A1 (en) * 2008-06-26 2009-12-30 sanofi-aventis Substituted N-Oxide pyrazine derivatives
EP2138488A1 (en) * 2008-06-26 2009-12-30 sanofi-aventis 4-(pyridin-4-yl)-1H-[1,3,5]triazin-2-one derivatives as GSK3-beta inhibitors for the treatment of neurodegenerative diseases
CN109776489B (zh) * 2019-02-26 2021-03-30 温州大学 铜催化苯丙炔胺硫环化合成1,2-二硫-3-硫酮衍生物的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957925A (en) * 1971-07-22 1976-05-18 Petrolite Corporation Thiophosphates
US3791789A (en) * 1972-06-22 1974-02-12 Petrolite Corp 1,2-dithiolium compounds as corrosion inhibitors

Also Published As

Publication number Publication date
ATA90177A (de) 1978-08-15
ES458019A1 (es) 1978-08-16
PT66174B (fr) 1978-07-10
LU76727A1 (US06312121-20011106-C00033.png) 1977-08-18
OA05566A (fr) 1981-04-30
NL7701103A (nl) 1977-08-12
DK55677A (da) 1977-08-11
AR220892A1 (es) 1980-12-15
AU505778B2 (en) 1979-11-29
US4104386A (en) 1978-08-01
NL175823C (nl) 1985-01-02
JPS625912B2 (US06312121-20011106-C00033.png) 1987-02-07
DE2705582B2 (US06312121-20011106-C00033.png) 1980-08-21
EG13192A (en) 1982-12-31
GB1520231A (en) 1978-08-02
AT349028B (de) 1979-03-12
CH616161A5 (US06312121-20011106-C00033.png) 1980-03-14
PH12622A (en) 1979-07-05
SE7701459L (sv) 1977-08-11
DE2705582A1 (de) 1977-08-11
HU172527B (hu) 1978-09-28
NL175823B (nl) 1984-08-01
IL51402A (en) 1980-07-31
SE427273B (sv) 1983-03-21
AU2213977A (en) 1978-08-17
IL51402A0 (en) 1977-04-29
CA1075239A (en) 1980-04-08
PT66174A (fr) 1977-03-01
SU837324A3 (ru) 1981-06-07
IE44462B1 (en) 1981-12-02
ATA71978A (de) 1978-08-15
IE44462L (en) 1977-08-10
JPS52105181A (en) 1977-09-03
AT349029B (de) 1979-03-12

Similar Documents

Publication Publication Date Title
DE2705582C3 (de) 5-(Pyridazin-3-yl)-1,2-dithiol-3-thion, seine Herstellung und die es enthaltenden Zusammensetzungen
DE3204596C2 (US06312121-20011106-C00033.png)
EP0044088B1 (de) p-Methoxybenzoyl-Derivate
DE2141634C3 (de) Neue Isoindolinderivate, ihre Herstellung und Zusammensetzungen, die sie enthalten
DE2947624A1 (de) Beta, gamma -dihydropolyprenylalkohol und diesen enthaltendes blutdrucksenkendes arzneimittel
DE2625012A1 (de) Arzneimittel zur heilung von leberkrankheiten
DE1470074C3 (de) 1,2,3,4,6,7-Hexahydro-l lbH-benzo eckige Klammer auf a eckige Klammer zu chinolizine sowie deren Acetate und/oder phsiologisch verträgliche Säureadditionssalze sowie Verfahren zu ihrer Herstellung
AT391699B (de) Verfahren zur herstellung neuer 4-chloro substituierter furo-(3,4-c)-pyridinderivate
DE69309461T2 (de) Zusammensetzung zur Beschleunigung der Wundheilung
DE2502504C3 (de) Phenothiazinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
EP0313935B1 (de) Enolether von 6-Chlor-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carbonsäureamid-1,1-dioxid, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE3323105C2 (de) Dithiolan-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2633891C2 (de) Tris-(hydroxymethyl)-aminomethansalz der 2-(5-Benzoylthienyl)-α-methylessigsäure, Verfahren zu dessen Herstellung und dieses enthaltende pharmazeutische Zusammensetzungen
DE3024323C2 (US06312121-20011106-C00033.png)
DE2351292C3 (de) 2,10-Dichlor-6-äthoxycarbonyl-12-methyl-12H-dibenzo[d,g][1,3]dioxocin und Verfahren zu dessen Herstellung sowie diese Verbindung enthaltende Arzneimittel
EP1270576B1 (de) 3-Phenyl-3,7-diazabicyclo(3,3,1)nonan-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0030343A1 (de) Substituierte 2-Amino-3,4-dihydropyridinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE1804448C3 (de) β-(2-p-Chlorphenyl-thiazol-4-yl)-acrylsäure, pharmazeutisch verträgliche Salze davon und Verfahren zur Herstellung der Verbindung
DE2733056C2 (de) Vincamenin und seine Säureadditionssalze, solche enthaltende Arzneimittel sowie Verfahren zur Herstellung der genannten Verbindungen
DE2917890C2 (US06312121-20011106-C00033.png)
DE3146867C2 (US06312121-20011106-C00033.png)
DE1941933C3 (de) Basisch substituierte 10,11- Dihydro-5,10-endoxa-SH-dibenzo- [a,d] -cycloheptene und deren pharmakologisch verträgliche Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0095641A1 (de) Chinazolinonderivate, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4041074A1 (de) Thiadiazinonderivate
WO1998035952A1 (de) Oxirancarbonsäuren für die behandlung von diabetes

Legal Events

Date Code Title Description
OD Request for examination
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee